Current Affairs - Business - Discussion

HCL Technologies has acquired C3i Solutions for USD 60 million, in a move to enhance HCL's growth in life sciences and consumer services. C3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, which is known as MSD outside the US and Canada. It offers multi-channel customer engagement services for life sciences and consumer packaged goods (CPG) industries. C3i's expertise in the clinical, pharmacovigilance, and pharma sales support domains will help HCL offer more patient-centric services and enhanced services to its life sciences customers. HCL Technologies will acquire 100% stock of Telerx Marketing that operates as C3i Solutions, through HCL's step down subsidiary - HCL America Inc.